home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Navigating the Medical Device Post-Market Maze and Challenges during COVID-19 Pandemic - Learn what FDA is really thinking on regulation and guidance documents

 
  February 03, 2021  
     
 
ComplianceOnline, online event
18 February 2021


DAY 01(10:00 AM - 4:00 PM EDT)
  • Introduction (15 mins)
  • Session 1
    • Complaint Handling and FDA Expectations (90 mins)
  • Break (15 mins)
  • Session 2
    • Continuation Complaint Handling and FDA Expectations (30 mins)
    • Medical Device Reporting Procedures (MDR) Regulations, Procedures, and Malfunctions (60 min)
  • Lunch Break (45 mins)
  • Session 3
    • Continuation of Medical Device Reporting Procedures (MDR) Regulations, Procedures, and Malfunctions (60 min)
    • MDR reporting by firm, agents Voluntary Malfunction Summary Reporting (VMSR) and eMDR Discussion (30 min)
  • Break (15 mins)
  • Session 4
    • Guidance Documents Update (30mins)
    • Being Recall Ready (30mins)
    • Questions and Recap (10 mins)
DAY 02(10:00 AM - 4:00 PM EDT)
  • Session 1
    • Recalls, Definition and Legal Authority Overview (60 mins)
    • Corrective and Preventative Actions (CAPA) (30 mins)
  • Break (15 mins)
  • Session 2
    • Health Hazard Evaluations HHE/HRA (30 mins)
    • Elements of a Correction and Removal -- 806 Reporting (45 mins)
  • Lunch Break (45 mins)
  • Session 3
    • Developing Effective Strategies / Communicating and Negotiating with FDA (45mins)
    • Notifications Letters and Press Releases (20 mins)
    • Silent Recalls / Product Enhancements and Enforcement Actions (20 mins)
  • Break (10 mins)
  • Session 4
    • Product Retrieval (20 mins)
    • Status Reports (20 mins)
    • Effectiveness Checks Follow-up Planning (20 mins)
    • Terminating a Recall (15 mins)
    • Wrap-up (5 mins)
 
 
Organized by: ComplianceOnline
Invited Speakers:

Rita Hoffman, RAC. Managing Partner Regs & Recall Strategies, LLC .Ms. Hoffman has more than 36 years of FDA experience across the device, drug and veterinary industries. She has an intimate understanding of FDA regulatory and compliance issues from the perspective of both FDA and regulated industry. As an FDA compliance consultant, she provides clients with regulatory insight, advises on critical compliance deficiencies, performs compliance and new product audits, provides insight and guidance on recall strategies to the medical device industry, and advises on jurisdiction determinations for combination products.

Ms. Hoffman retired from the FDA in January 2011 as the Recall Branch Chief for the Center for Devices and Radiological Health (CDRH), where she was responsible for oversight and review for all medical device recalls. Ms. Hoffman held several positions including the Center for Drug Evaluation and Research (CDER) Jurisdiction Review Officer (providing guidance on drug/device product designation, combination products and co-packaging), Acting Associate Ombudsman, Small Business Liaison, and was a Policy Analyst for eight years in the Office of the Commissioner. She served as co-chair of RAPS’ Baltimore/Washington Metropolitan Area Chapter for 2-terms, and in 2008 was presented with the Special Recognition Award by RAPS.

 
Deadline for Abstracts: 17.2.2021
 
Registration: Register by phone or need assistance? Call +1-888-717-2436

E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.